Alterity Therapeutics (ATHE) Long-Term Deferred Tax (2017 - 2025)
Alterity Therapeutics (ATHE) posted quarterly Long-Term Deferred Tax of $31.9 million for Q2 2025, up 1.51% year-over-year from $31.5 million in Q2 2024, and up 1.51% quarter-over-quarter from $31.5 million in Q2 2024.
Alterity Therapeutics (ATHE) Long-Term Deferred Tax (2017 - 2025) Analysis & Trends
Alterity Therapeutics' Long-Term Deferred Tax history runs 9 years deep, the most recent figure standing at $31.9 million for Q2 2025.
- In Q2 2025, Long-Term Deferred Tax rose 1.51% year-over-year to $31.9 million; the TTM figure through Jun 2025 stood at $31.9 million (up 1.51% YoY), while the FY2025 annual figure was $31.9 million, up 1.51% from the prior year.
- Long-Term Deferred Tax for Q2 2025 stood at $31.9 million, up from $31.5 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $31.9 million in Q2 2025, with the low at $29.4 million in Q2 2023.
- The 5-year median for Long-Term Deferred Tax is $31.5 million (2024), against an average of $30.8 million.
- The sharpest annual moves came in 2021 and 2022: Long-Term Deferred Tax climbed 20.68% in 2021, then declined 7.03% in 2022.
- Alterity Therapeutics' Long-Term Deferred Tax stood at $31.7 million in 2021, then retreated by 7.03% to $29.5 million in 2022, then fell by 0.23% to $29.4 million in 2023, then gained by 6.89% to $31.5 million in 2024, then gained by 1.51% to $31.9 million in 2025.
- Business Quant data shows ATHE's Long-Term Deferred Tax at $31.9 million in Q2 2025, $31.5 million in Q2 2024, and $29.4 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Alterity Therapeutics | 48.56 Mn | 16.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 31.95 Mn |
| Jun 30, 2024 | 31.47 Mn |
| Jun 30, 2023 | 29.45 Mn |
| Jun 30, 2022 | 29.51 Mn |
| Jun 30, 2021 | 31.74 Mn |
| Jun 30, 2020 | 26.30 Mn |
| Jun 30, 2019 | 25.16 Mn |
| Jun 30, 2018 | 26.02 Mn |
| Jun 30, 2017 | 25.26 Mn |